BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17130629)

  • 1. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
    Douglas CE; Davis RM; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.
    Milberger S; Davis RM; Douglas CE; Beasley JK; Burns D; Houston T; Shopland D
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv17-26. PubMed ID: 17130620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.
    Davis RM; Douglas CE; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv4-8. PubMed ID: 17130623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.
    Goldberg ME; Davis RM; O'Keefe AM
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv54-67. PubMed ID: 17130625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying lessons from tobacco litigation to obesity lawsuits.
    Alderman J; Daynard RA
    Am J Prev Med; 2006 Jan; 30(1):82-8. PubMed ID: 16414429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco industry lawyers as "disease vectors".
    Guardino SD; Daynard RA
    Tob Control; 2007 Aug; 16(4):224-8. PubMed ID: 17652236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economics on trial: the use and abuse of economic methods in third party tobacco litigation.
    Max W; Tsoukalas T
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv77-83. PubMed ID: 17130627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Product liability.
    Daynard RA; Legresley E
    Tob Control; 2012 Mar; 21(2):227-8. PubMed ID: 22345254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Litigation in Argentina: challenging the tobacco industry.
    Flores ML; Barnoya J; Mejia R; Alderete E; PĂ©rez-Stable EJ
    Tob Control; 2006 Apr; 15(2):90-6. PubMed ID: 16565455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lawyer control of internal scientific research to protect against products liability lawsuits. The Brown and Williamson documents.
    Hanauer P; Slade J; Barnes DE; Bero L; Glantz SA
    JAMA; 1995 Jul; 274(3):234-40. PubMed ID: 7609232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Application of Philip Morris' Litigation Prevention Program in South Korea.
    Kim JH; Kim J; Lee S
    Asia Pac J Public Health; 2021; 33(2-3):188-195. PubMed ID: 33383993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of litigation in tobacco control.
    Miura M; Daynard RA; Samet JM
    Salud Publica Mex; 2006; 48 Suppl 1():S121-36. PubMed ID: 17684674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are artificial tans the new cigarette? How plaintiffs can use the lessons of tobacco litigation in bringing claims against the indoor tanning industry.
    Loh AY
    Mich Law Rev; 2008 Nov; 107(2):365-90. PubMed ID: 19031654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scottish court dismisses a historic smoker's suit.
    Friedman L; Daynard R
    Tob Control; 2007 Oct; 16(5):e4. PubMed ID: 17897973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential reduced exposure products (PREPs) in industry trial testimony.
    Wayne GF
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv90-7. PubMed ID: 17130630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
    Tan CE; Kyriss T; Glantz SA
    PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of industry responsibility and tobacco control policy by US tobacco company executives in trial testimony.
    Chaiton M; Ferrence R; LeGresley E
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv98-106. PubMed ID: 17130631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The divergence between scientific and legal approaches concerning the cause of effects of tobacco use under Spanish law.
    Arcos Vieira ML
    Med Law; 2010 Jun; 29(2):171-82. PubMed ID: 22462282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Philip Morris's pursuit of US government regulation of tobacco.
    McDaniel PA; Malone RE
    Tob Control; 2005 Jun; 14(3):193-200. PubMed ID: 15923470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.